|
|
||||||||
Currently available artemisinin-based combination therapies (ACTs) for malaria are inadequate. There remains an enormous unmet need for alternate artemisinin-based combination therapies. One of the fastest methods to identify promising artemisinin-based combination therapies is to look for synergistic or additive antimalarial interaction between artemisinin and an alternate drug against P. falciparum in vitro. Amphotericin B and clotrimazole are known drugs for treatment of human fungal infections. We repurposed clotrimazole or heat-treated amphotericin B in fixed ratio combination with artemisinin for antimalarial properties. Isobologram results show synergistic/additive interaction in both of the cases at therapeutically safe concentrations. Artemisinin, clotrimazole, and their synergistic combinations also decrease hemozoin production in parasitized erythrocytes. New permeation pathways induced in infected cells remain unaffected by drug combinations as indicated by sorbitol lysis. It would be interesting to extend the studies in vivo system.
Received October 22, 2007. Accepted for publication December 28, 2007.
Acknowledgments: This work was supported in part by the Department of Biotechnology, Ministry of Science and Technology, Government of India. A.B. and L.C.M. received fellowship from the Council of Scientific and Industrial Research, New Delhi, India.
* Address correspondence to Virendra K. Bhasin, Department of Zoology, University of Delhi, Delhi 110007, India. E-mail: virendrabhasin{at}hotmail.com
Authors addresses: Amit Bhattacharya, Lokesh C. Mishra, and Virendra K. Bhasin, Department of Zoology, University of Delhi, Delhi 110007, India, Telephone: 91-11-27667989, Fax: +91-11-27667524, E-mail: virendrabhasin{at}hotmail.com.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |